Immunisbio a company specializing in immune cell therapy that realizes the value of respect for life, is dedicated to developing various intractable immune disease treatments including cancer. The NK immune cell therapy 'MYJ1633' has been commercialized overseas as a cancer treatment, and a number of university hospitals in Korea are conducting commercial clinical trials such as breast cancer, stomach cancer and peritoneal metastatic gastrointestinal cancer. We are researching production automation using our own cell culture, cell activation, and automation technology and we are expanding our business by supplying cell culture solutions that are in the spotlight as biostatic raw materials. We will contribute to a healthy life for mankind by creating synergy between each business.
moreEXHIBIT
Human Regulatory T Cell Conditioned Media Extract
Treg cell culture Medium for cosmetic raw materials
More
Human Blood Derived Natural Killer Cell Conditioned Media Extract
NK cell culture Medium for cosmetic raw materials
More
MYJ1633
NK cell therapy drug for cancer treatment. The Ministry of Food and Drug Safety is conducting commercial clinical trials in Korea (phase 2 of gastric cancer, phase 1/2a of gastrointestinal cancer, and phase 1/2a of HER-2 breast cancer). It is used as a cell therapy for cancer treatment in Japan, Vietnam, Malaysia, and Laos.
More
COMPANY INTRODUCTION
Immunisbio a company specializing in immune cell therapy that realizes the value of respect for life, is dedicated to developing various intractable immune disease treatments including cancer. The NK immune cell therapy 'MYJ1633' has been commercialized overseas as a cancer treatment, and a number of university hospitals in Korea are conducting commercial clinical trials such as breast cancer, stomach cancer and peritoneal metastatic gastrointestinal cancer. We are researching production automation using our own cell culture, cell activation, and automation technology and we are expanding our business by supplying cell culture solutions that are in the spotlight as biostatic raw materials. We will contribute to a healthy life for mankind by creating synergy between each business.
